LCM Capital Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $511K | Buy |
1,148
+4
| +0.3% | +$1.78K | 0.27% | 50 |
|
|
2025
Q1 | $555K | Buy |
1,144
+71
| +7% | +$34.4K | 0.33% | 47 |
|
|
2024
Q4 | $432K | Buy |
1,073
+19
| +2% | +$7.65K | 0.24% | 55 |
|
|
2024
Q3 | $490K | Buy |
1,054
+58
| +6% | +$27K | 0.28% | 51 |
|
|
2024
Q2 | $467K | Buy |
996
+56
| +6% | +$26.2K | 0.29% | 49 |
|
|
2024
Q1 | $393K | Buy |
940
+14
| +2% | +$5.85K | 0.25% | 55 |
|
|
2023
Q4 | $377K | Buy |
926
+16
| +2% | +$6.51K | 0.27% | 55 |
|
|
2023
Q3 | $316K | Buy |
910
+113
| +14% | +$39.3K | 0.26% | 57 |
|
|
2023
Q2 | $280K | Buy |
797
+39
| +5% | +$13.7K | 0.23% | 67 |
|
|
2023
Q1 | $239K | Buy |
+758
| New | +$239K | 0.21% | 74 |
|